Synergistic effect of SCH 58261, an adenosine A2A receptor antagonist, and L-DOPA on the reserpine-induced muscle rigidity in rats

Polish Journal of Pharmacology

Volumn 55, Issue 2, 2003, Pages 155-164

  Wardas, Jadwiga ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Adenosine A2A receptors; L DOPA; Mechano and electromyogram; Muscle rigidity; Parkinsonism; Reserpine; SCH 58261

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR ANTAGONIST; ANTIPARKINSON AGENT; LEVODOPA; METIROSINE; RESERPINE;

ANKLE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; DRUG SELECTIVITY; ELECTROMYOGRAPHY; GASTROCNEMIUS MUSCLE; HINDLIMB; JOINT LIMITATION; MALE; MUSCLE FUNCTION; MUSCLE RIGIDITY; MUSCLE TONE; NONHUMAN; PARKINSON DISEASE; RAT; RECEPTOR BLOCKING; STATISTICAL SIGNIFICANCE; TIBIALIS ANTERIOR MUSCLE;

ANIMALS; ANKLE JOINT; ANTIPARKINSON AGENTS; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; ELECTROMYOGRAPHY; LEVODOPA; MALE; MUSCLE RIGIDITY; MUSCLE, SKELETAL; PYRIMIDINES; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A2A; RESERPINE; TRIAZOLES;

EID: 0038107447     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. 2A receptor antagonist. J. Neurosci., 2000, 20, 5848-5852.
2. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F.: Brain dopamine and the syndromes of Parkinson and Huntington, J. Neural Sci., 1973, 20, 415.
3. 2a purine receptors regulate striatal acetycholine release. J. Neurochem., 1990, 55, 31-38.
4. 2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats. Eur. J. Pharmacol., 1997, 321, 143-147.
5. 2 receptors in the neostriatum. Brain Res., 1992, 594, 124-130.
6. Ferre S., O'Connor W.T., Fuxe K., Ungerstedt U.: The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. J. Neurosci., 1993, 13, 5402-5406.
7. Ferre S., Rubio A., Fuxe K.: Stimulation of adenosine A2 receptors induces catalepsy. Neurosci. Lett., 1991, 130, 162-165.
8. Fink J.S., Weaver D.R., Rivkees S.A., Peterfreund S.A., Pollack A.E., Adler A.M., Reppert S.M.: Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. Mol. Brain Res., 1992, 14, 186-195.
9. Fisher A., Biggs C.S., Eradiri O., Starr M.S.: Dual effect of L-3,4-dihydroxyphenylalanine on aromatic L-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: evidence that behaviour is dopamine independent. Neuroscience, 2000, 95, 97-111.
10. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J. Jr., Sibley D.R.: D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science, 1990, 250, 1429-1432.
11. 2A receptor blockade on L-DOPA biotransormation in nigrostriatal dopamine neurons. FENS Abstr., 2002, 1, A012.7.
12. 2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys. Ann. Neurol., 1998, 43, 507-513.
13. 2A antagonist with anticataleptic activity. Eur. J. Pharmacol., 1994, 256, 263-268.
14. 2A receptor in basal ganglia. Biosci. Biotechnol. Biochem., 2001, 65, 1447-1457.
15. 3H]ace-tylcholine release. J. Neurochem., 1994, 62, 960-966.
16. 2A receptor mediated modulation of striatal GABA and Ach release. Brit. J. Pharmacol., 1994, 113, 43-48.
17. 2 dopamine receptor supersensitivity as indicated by striatal and pallidal Fos expression. Neurosci. Lett., 1994, 179, 153-158.
18. LaHoste G.J,, Yu J., Marshall J.F.: Striatal fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. Proc. Nat. Acad. Sci. USA, 1993, 90, 7451-7455.
19. Lee R.G.: Pathophysiology of rigidity and akinesia in Parkinson's disease. Eur. Neurol. 1989, 29, 13-18.
20. 2A receptors enhances D1 receptor-mediated effects on c-fos expression. J. Neurosci., 1997, 17, 8038-8048.
21. Lorenc-Koci E., Ossowska K., Wardas J., Wolfarth S.: Does reserpine induce parkinsonian rigidity? J. Neural Transm.-Parkinsons, 1995, 9, 211-223.
22. Lorenc-Koci E., Wolfarth S.: Efficacy of pramipexole, a new dopamine receptor agonist, to relieve the parkinsonian-like muscle rigidity in rats. Eur. J. Pharmacol., 1999, 385, 39-46.
23. Lorenc-Koci E., Wolfarth S., Ossowska K.: Haloperidol-increased muscle tone in rats as a model of parkinsonian rigidity. Exp. Brain Res., 1996, 109, 268-276.
24. Mandhane S.N., Chopde CH.T., Ghosh A.K.: Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats. Eur. J. Pharmacol., 1997, 328, 135-141.
25. 2 receptors in unilaterally 6-hydroxydopamine-lesioned rats. Eur. J. Pharmacol., 1994, 251, 21-25.
26. 2a receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons. J. Neurosci., 1996, 16, 605-611.
27. Mortimer J.A., Webster D.D.: Evidence for a quantitative association between EMG stretch responses and parkinsonian rigidity. Brain Res., 1979, 162, 169-173.
28. 2A receptor antagonist reverses increased GABA release in the globus pallidus of unilaterally 6-hydroxydopamine-lesioned rats: a microdialysis study. Neuroscience, 2000, 100, 52-62.
29. 1 agonists in dopamine-denervated rats. Eur. J. Neurosci., 1996, 8, 1176-1181.
30. 2a adenosine receptor mRNA with D1 and D2 dopamine receptor mRNA in striatal output pathways following a selective lesion of striatonigral neurons. Brain Res., 1993, 631, 161-166.
31. 2A receptor antagonists as new agents for the treatment of Parkinson's disease. Trends Pharmacol. Sci., 1997, 18, 338-344.
32. Ross S.B., Jackson M., Wallis E.M., Edwards S.R.: Enhancement by a single dose of reserpine (plus alpha methyl-p-tyrosine) of the central stimulatory effects evoked by dopamine D-1 and D-2 agonists in the mouse. Naunyn-Schmied, Arch. Pharmacol., 1988, 337, 512-518.
33. 2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J. Neurochem., 1991, 57, 1062-1067.
34. 2A receptors. Prog. Neurobiol., 1999, 59, 355-396.
35. 2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience, 1997, 80, 1171-1185.
36. 14C-2-deoxyglucose autoradiography. J. Neurosci., 1992, 12, 2875-2879.
37. 2A receptors in regulation of the muscle tone in rats. Neurosci. Lett., 1999, 276, 79-82.
38. 2A adenosine receptor antagonist, counteracts the parkinsonian-like muscle rigidity in rats. Synapse, 2001, 41, 160-171.
39. Wolfarth S., Konieczny J., Śmiałowska M., Schulze G., Ossowska K.: Influence of 6-hydroxydopamine lesion of the dopaminergic nigrostriatal pathway on the muscle tone and electromyographic activity measured during passive movements. Neuroscience, 1996, 74, 985-996.
40. 2A adenosine receptor antagonist. J. Pharmacol. Exp. Ther., 1996, 276, 389-404.